melanocortin 1 receptor
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The MC1R gene provides instructions for making a protein called the melanocortin 1 receptor. This receptor plays an important role in normal pigmentation. The receptor is primarily located on the surface of melanocytes, which are specialized cells that produce a pigment called melanin. Melanin is the substance that gives skin, hair, and eyes their colour. Melanin is also found in the light-sensitive tissue at the back of the eye (the retina), where it plays a role in normal vision.
Video picks for GenesVideo library
Normal function
The MC1R gene provides instructions for making a protein called the melanocortin 1 receptor. This receptor plays an important role in normal pigmentation. The receptor is primarily located on the surface of melanocytes, which are specialized cells that produce a pigment called melanin. Melanin is the substance that gives skin, hair, and eyes their colour. Melanin is also found in the light-sensitive tissue at the back of the eye (the retina), where it plays a role in normal vision.
Melanocytes make two forms of melanin, eumelanin and pheomelanin. The relative amounts of these two pigments help determine the colour of a person's hair and skin. People who produce mostly eumelanin tend to have brown or black hair and dark skin that tans easily. Eumelanin also protects skin from damage caused by ultraviolet (UV) radiation in sunlight. People who produce mostly pheomelanin tend to have red or blond hair, freckles, and light-colored skin that tans poorly. Because pheomelanin does not protect skin from UV radiation, people with more pheomelanin have an increased risk of skin damage caused by sun exposure.
The melanocortin 1 receptor controls which type of melanin is produced by melanocytes. When the receptor is activated, it triggers a series of chemical reactions inside melanocytes that stimulate these cells to make eumelanin. If the receptor is not activated or is blocked, melanocytes make pheomelanin instead of eumelanin.
Common variations (polymorphisms) in the MC1R gene are associated with normal differences in skin and hair colour. Certain genetic variations are most common in people with red hair, fair skin, freckles, and an increased sensitivity to sun exposure. These MC1R polymorphisms reduce the ability of the melanocortin 1 receptor to stimulate eumelanin production, causing melanocytes to make mostly pheomelanin. Although MC1R is a key gene in normal human pigmentation, researchers believe that the effects of other genes also contribute to a person's hair and skin coloring.
The melanocortin 1 receptor is also active in cells other than melanocytes, including cells involved in the body's immune and inflammatory responses. The receptor's function in these cells is unknown.
Conditions referring to this gene or chromosome
Other names
MC1-R
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
Melanocortin-1 receptor
melanocyte stimulating hormone receptor
melanotropin receptor
MSH-R
MSHR_HUMAN
Patient picks for Genes

Medicine
Olmesartan - an angiotensin receptor blocker
Take olmesartan once each day. You can take your doses either before or after a meal. Keep your regular appointments with your doctor to have your blood pressure measured. Some painkillers can interfere with olmesartan and increase the risk of side-effects, so ask a pharmacist for advice before you buy any medicines 'over the counter'.
by Michael Stewart, MRPharmS

PID Q&A
Does PID cause bleeding?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

Medicine
Candesartan - an angiotensin receptor blocker
Take candesartan once each day. You can take the tablets either before or after a meal. Any side-effects are usually mild. They include headache and feeling dizzy. Some painkillers may interfere with candesartan and increase the risk of side-effects, so ask a pharmacist for advice before you buy any medicines.
by Michael Stewart, MRPharmS

Breast cancer
How often is breast cancer misdiagnosed?
Dr Sarah Jarvis MBE Finding out the stage of the cancer, the grade of the cells and the receptor status of the cancer helps doctors to advise on the best treatment options. It also gives a reasonable indication of outlook. [https://patient.info/health/breast-cancer-leaflet#nav-5](https://patient.info/health/breast-cancer-leaflet#nav-5)
by Dr Sarah Jarvis

Medicine
Irbesartan - an angiotensin receptor blocker
Take irbesartan once each day. You can take the tablets before or after meals. Side-effects are usually mild. They include feeling dizzy and mild stomach upset. Keep your regular appointments with your doctor to have your blood pressure measured. Some painkillers interfere with irbesartan, so ask a pharmacist for advice before you buy any medicines.
by Michael Stewart, MRPharmS

Medicine
Losartan - an angiotensin receptor blocker
Take losartan once each day. You can take your doses either before or after a meal. Any side-effects are usually mild, and can include feeling dizzy or light-headed. Some painkillers can interfere with losartan and increase the risk of side-effects, so ask a pharmacist for advice before you buy any medicines 'over the counter'. Do not drink grapefruit juice whilst taking losartan. It can interact with the medicine and alter its effect.
by Michael Stewart, MRPharmS
Related patient information and medicines

Patient information leaflet
Mastocytosis and mast cell disorders
If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (such as interferon), bone marrow transplant or... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Patient information leaflet
Diabetic kidney disease
They should only be used in type 1 diabetes under the direction of a diabetes specialist. Finerenone Finerenone is a new drug which blocks the action of certain hormones (mineralocorticoids) which may damage the kidneys. In the UK, it's currently recommended as an option for people with type 2 diabetes who have stage 3 or 4 kidney disease and.

Patient information leaflet
Myasthenia gravis
Myasthenia gravis (MG) is a condition where muscles become easily tired and weak. It is due to a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. What causes myasthenia gravis. Myasthenia gravis is an autoimmune disease. This means that the immune system The immune.

Patient information leaflet
Dilated cardiomyopathy
Dilated cardiomyopathy is a condition where the heart muscle becomes stretched and thin. The heart becomes enlarged (dilates) and pumps blood less well. Symptoms vary according to severity and the treatment depends on the type of symptoms and whether any complications develop. Some forms of dilated cardiomyopathy run in families. A normal heart.

Patient information leaflet
Vaginal dryness
You may... This may make the area also look slightly different to how it was before the menopause. Vaginal dryness is a common symptom of the menopause; after the menopause at least half of women have some symptoms related to vaginal dryness and thinning of the vaginal tissue. You are also more likely to experience symptoms as more years pass.

Patient information leaflet
Breast cancer
About 48,000 cases occur in the UK each year. Breast cancer develops from a cancerous (malignant) cell which develops in the lining of a duct or lobule in one of the breasts. [https://patient.info/health/breast-cancer-leaflet#nav-0](https://patient.info/health/breast-cancer-leaflet#nav-0) Types of breast cancer Carcinoma in situ Some people are.
Further reading and references
- melanocortin 1 receptor; MedlinePlus, National Library of Medicine.
- Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR, Hayward NK, Martin NG, Sturm RA. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet. 2004 Feb 15;13(4):447-61. doi: 10.1093/hmg/ddh043. Epub 2004 Jan 6.
- Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res. 2005 Dec;18(6):393-410. doi: 10.1111/j.1600-0749.2005.00278.x.
- Ha T, Naysmith L, Waterston K, Oh C, Weller R, Rees JL. Defining the quantitative contribution of the melanocortin 1 receptor (MC1R) to variation in pigmentary phenotype. Ann N Y Acad Sci. 2003 Jun;994:339-47. doi: 10.1111/j.1749-6632.2003.tb03198.x.
- Healy E. Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility. Photodermatol Photoimmunol Photomed. 2004 Dec;20(6):283-8. doi: 10.1111/j.1600-0781.2004.00132.x.
- Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 2006 Sep 15;66(18):9330-7. doi: 10.1158/0008-5472.CAN-06-1634.
- King RA, Willaert RK, Schmidt RM, Pietsch J, Savage S, Brott MJ, Fryer JP, Summers CG, Oetting WS. MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet. 2003 Sep;73(3):638-45. doi: 10.1086/377569. Epub 2003 Jul 22.
- Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, Bastian BC. MC1R germline variants confer risk for BRAF-mutant melanoma. Science. 2006 Jul 28;313(5786):521-2. doi: 10.1126/science.1127515. Epub 2006 Jun 29.
- Mumm CD, Draznin M. Melanocortin-1 receptor: loss of function mutations and skin cancer. Dermatol Online J. 2006 Sep 8;12(5):13.
- Rees JL. Genetics of hair and skin color. Annu Rev Genet. 2003;37:67-90. doi: 10.1146/annurev.genet.37.110801.143233.
- Rees JL. The genetics of sun sensitivity in humans. Am J Hum Genet. 2004 Nov;75(5):739-51. doi: 10.1086/425285. Epub 2004 Sep 15.
- Rouzaud F, Kadekaro AL, Abdel-Malek ZA, Hearing VJ. MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res. 2005 Apr 1;571(1-2):133-52. doi: 10.1016/j.mrfmmm.2004.09.014. Epub 2005 Jan 26.
- Sturm RA. Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res. 2002 Oct;12(5):405-16. doi: 10.1097/00008390-200209000-00001.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

